+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Sepsis Therapeutics Market 2019-2023 - Product Image

Global Sepsis Therapeutics Market 2019-2023

  • ID: 4662768
  • Report
  • October 2018
  • Region: Global
  • 112 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

FEATURED COMPANIES

  • Akorn
  • Baxter
  • Fresenius
  • Novartis
  • Pfizer
  • MORE
About Sepsis

Sepsis refers to the human body’s systemic inflammatory response to microbial infections. This results in impaired blood flow, which damages the organs. Antibiotics and vasopressors are the most commonly available medications for the treatment of sepsis.

The analysts forecast the Global Sepsis Therapeutics Market to grow at a CAGR of 5.41% during the period 2019-2023.

Covered in this report
The report covers the present scenario and the growth prospects of the sepsis therapeutics market. To calculate the market size, the report considers the revenue generated from the application of sepsis therapeutics across the globe.

The market is divided into the following segments based on geography:
  • Americas
  • APAC
  • EMEA
The report, sepsis therapeutics market 2019-2023, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Akorn
  • Baxter
  • Fresenius
  • Novartis
  • Pfizer
Market drivers
  • High prevalence of sepsis
  • For a full, detailed list, view the full report
Market challenges
  • Product withdrawals
  • For a full, detailed list, view the full report
Market trends
  • Strategic alliances
  • For a full, detailed list, view the full report
Key questions answered in this report
  • What will the market size be in 2023 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the Key vendors?
  • What are the strengths and weaknesses of the key vendors?
You can request one free hour of the analyst’s time when you purchase this market report. Details are provided within the report.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Akorn
  • Baxter
  • Fresenius
  • Novartis
  • Pfizer
  • MORE
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: MARKET LANDSCAPE
  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
PART 04: MARKET SIZING
  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
PART 06: CUSTOMER LANDSCAPE

PART 07: MARKET SEGMENTATION BY PRODUCT
  • Market segmentation by product
  • Comparison by product
  • Antimicrobial therapy - Market size and forecast 2018-2023
  • Adjunctive therapy - Market size and forecast 2018-2023
  • Market opportunity by product
PART 08: GEOGRAPHIC LANDSCAPE
  • Geographic segmentation
  • Geographic comparison
  • Americas - Market size and forecast 2018-2023
  • EMEA - Market size and forecast 2018-2023
  • APAC - Market size and forecast 2018-2023
  • Market opportunity
PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges
PART 11: MARKET TRENDS

PART 12: VENDOR LANDSCAPE
  • Overview
  • Landscape disruption
  • Competitive scenario
PART 13: VENDOR ANALYSIS
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Akorn
  • Baxter
  • Fresenius
  • Novartis
  • Pfizer
PART 14: APPENDIX
  • Research methodolog
  • List of abbreviations
PART 15: About the Author


List of Exhibits
Exhibit 01: Global infectious disease therapeutics market
Exhibit 02: Segments of global infectious disease therapeutics market
Exhibit 03: Market characteristics
Exhibit 04: Market definition - Inclusions and exclusions checklist
Exhibit 05: Market size 2018
Exhibit 06: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 07: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 08: Five forces analysis 2018
Exhibit 09: Five forces analysis 2023
Exhibit 10: Bargaining power of buyers
Exhibit 11: Bargaining power of suppliers
Exhibit 12: Threat of new entrants
Exhibit 13: Threat of substitutes
Exhibit 14: Threat of rivalry
Exhibit 15: Market condition - Five forces 2018
Exhibit 16: Product - Market share 2018-2023 (%)
Exhibit 17: Comparison by product
Exhibit 18: Antimicrobial therapy - Market size and forecast 2018-2023 ($ millions)
Exhibit 19: Antimicrobial therapy - Year-over-year growth 2019-2023 (%)
Exhibit 20: Adjunctive therapy - Market size and forecast 2018-2023 ($ millions)
Exhibit 21: Adjunctive therapy - Year-over-year growth 2019-2023 (%)
Exhibit 22: Market opportunity by product
Exhibit 23: Market share by geography 2018-2023 (%)
Exhibit 24: Geographic comparison
Exhibit 25: Americas - Market size and forecast 2018-2023 ($ millions)
Exhibit 26: Americas - Year-over-year growth 2019-2023 (%)
Exhibit 27: Top 3 countries in Americas
Exhibit 28: EMEA - Market size and forecast 2018-2023 ($ millions)
Exhibit 29: EMEA - Year-over-year growth 2019-2023 (%)
Exhibit 30: Top 3 countries in EMEA
Exhibit 31: APAC - Market size and forecast 2018-2023 ($ millions)
Exhibit 32: APAC - Year-over-year growth 2019-2023 (%)
Exhibit 33: Top 3 countries in APAC
Exhibit 34: Market opportunity
Exhibit 35: Prevalence of sepsis in US
Exhibit 36: Impact of drivers and challenges
Exhibit 37: Vendor landscape
Exhibit 38: Landscape disruption
Exhibit 39: Vendors covered
Exhibit 40: Vendor classification
Exhibit 41: Market positioning of vendors
Exhibit 42: Akorn - Vendor overview
Exhibit 43: Akorn - Business segments
Exhibit 44: Akorn - Organizational developments
Exhibit 45: Akorn - Segment focus
Exhibit 46: Akorn - Key offerings
Exhibit 47: Akorn - Key customers
Exhibit 48: Baxter - Vendor overview
Exhibit 49: Baxter - Business segments
Exhibit 50: Baxter - Organizational developments
Exhibit 51: Baxter - Geographic focus
Exhibit 52: Baxter - Segment focus
Exhibit 53: Baxter - Key offerings
Exhibit 54: Baxter - Key customers
Exhibit 55: Fresenius - Vendor overview
Exhibit 56: Fresenius - Business segments
Exhibit 57: Fresenius - Organizational developments
Exhibit 58: Fresenius - Geographic focus
Exhibit 59: Fresenius - Segment focus
Exhibit 60: Fresenius - Key offerings
Exhibit 61: Fresenius - Key customers
Exhibit 62: Novartis - Vendor overview
Exhibit 63: Novartis - Business segments
Exhibit 64: Novartis - Organizational developments
Exhibit 65: Novartis - Geographic focus
Exhibit 66: Novartis - Segment focus
Exhibit 67: Novartis - Key offerings
Exhibit 68: Novartis - Key customers
Exhibit 69: Pfizer - Vendor overview
Exhibit 70: Pfizer - Business segments
Exhibit 71: Pfizer - Organizational developments
Exhibit 72: Pfizer - Geographic focus
Exhibit 73: Pfizer - Segment focus
Exhibit 74: Pfizer - Key offerings
Exhibit 75: Pfizer - Key customers
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

FEATURED COMPANIES

  • Akorn
  • Baxter
  • Fresenius
  • Novartis
  • Pfizer
  • MORE
Global Sepsis Therapeutics Market 2019-2023

The author of the report recognizes the following companies as the key players in the global sepsis therapeutics market: Akorn, Baxter, Fresenius, Novartis, and Pfizer.

Commenting on the report, an analyst from the research team said: “One trend affecting this market is the strategic alliances. There are several pharmaceutical companies working together for the development of medications for the treatment of sepsis. These alliances will increase the research toward the development of new drugs for the management of sepsis.”

According to the report, one driver influencing this market is the high prevalence of sepsis. The rising prevalence of sepsis is expected to fuel the growth of the global sepsis therapeutics market.

Further, the report states that one challenge affecting this market is the product withdrawals. The global sepsis therapeutics market has an acute lack of approved therapies, resulting in huge unmet needs among sepsis patients and hampering the growth of the market.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 4
  • Akorn
  • Baxter
  • Fresenius
  • Novartis
  • Pfizer
Note: Product cover images may vary from those shown
Adroll
adroll